Two-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an oral peptide targeting interleukin (IL)-23, a randomized study showed. The ...

The TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to studies reported here. More than half of patients with psoriatic arthritis ...

With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...

The product, Yesintek (ustekinumab-kfce), has received approval for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis, and is now accessible to ...

L’Oréal Groupe has launched L’Oréal Act for Dermatology, a five-year skin health programme, under its Dermatological Beauty ...

AbbVie’s psoriasis drug risankizumab has posted strong ... One event occurred in the placebo arm in the first phase of the study and the other occurred in the risankizumab arm in the second ...

Stocks surged on Friday, with the S&P 500 soaring 2.13% as investors welcomed a break from tariff-driven turmoil. The market ...

The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...

A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to ...

WellTheory, a first-of-its-kind virtual solution for the 50 million Americans suffering with autoimmune disease, today released a groundbreaking Autoimmune Disease Impact Report in partnership with ...

Find Psoriasis Arm stock video, 4K footage, and other HD footage from iStock. Get higher quality Psoriasis Arm content, for less—All of our 4K video clips are the same price as HD. Video ...

Tata Power, Nazara Tech, Lupin, Biocon, JSW Steel, Shilpa Medicare, and Oriental Rail are some other stocks to watch today, March 10, 2025 ...